School of Medicine

Brian A. Van Tine, MD, PhD, a nationally recognized leader in sarcoma research at WashU Medicine, died Saturday, Nov. 8, 2025, at Barnes-Jewish Hospital following an acute illness. He was 53.

The WashU Medicine Pro Bono Health Clinic offers free occupational therapy, physical therapy and medical services to uninsured community members in the St. Louis area.

Meaghan Creed, an associate professor of anesthesiology at WashU Medicine, has received a $3.3 million five-year grant from the National Institute on Drug Abuse to study dopamine system changes underlying depression symptoms in people with chronic neuropathic pain.

Jeffrey I. Gordon, MD, the Dr. Robert J. Glaser Distinguished University Professor at WashU Medicine, co-leads a team that developed a therapeutic food designed to treat childhood malnutrition. The food was named one of Time Magazine’s Best Inventions of 2025.

Catherine E. Lang, a leading researcher in stroke recovery and rehabilitation in the WashU Medicine Program in Physical Therapy, has been installed as the inaugural Barbara J. Norton Professor of Physical Therapy.

A group of researchers from Washington University in St. Louis has created a new kind of fiber-optic device to manipulate neural activity deep in the brain.

WashU Medicine Mallinckrodt Institute of Radiology is establishing the Center for Computational and AI-enabled Imaging Sciences, in partnership with WashU’s McKelvey School of Engineering, to improve the diagnosis and precision treatment of cancers, cardiovascular disease, neurological diseases and numerous other conditions.

Ganesh Chand, an assistant professor at WashU Medicine Mallinckrodt Institute of Radiology, will study why some Alzheimer’s patients experience neuropsychiatric symptoms such as apathy and depression.

Farrokh Dehdashti, MD, the Drs. Barry A. and Marilyn J. Siegel Professor of Radiology at WashU Medicine Mallinckrodt Institute of Radiology, has received the Radiological Society of North America’s 2025 Outstanding Researcher Award.

Researchers at WashU Medicine have identified central routes that two deadly viruses take to invade human cells and designed “decoy” molecules to block the infections.